XARELTO
XARELTO
Approved
DIN Number
02510162
Drug Class
Human
Market Date
Jun 11, 2021
Company
HC
Bayer Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02510162
AIG Number0152487007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF01 RIVAROXABAN
Product Specifications
Dosage FormGranules For Suspension
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIVAROXABANActive
Strength: 51.7 MG / BOTTLE
Monograph: RIVAROXABAN